These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 2438389

  • 1. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients.
    Logothetis CJ, Swanson DA, Dexeus F, Chong C, Ogden S, Ayala AG, von Eschenbach AC, Johnson DE, Samuels ML.
    J Clin Oncol; 1987 Jun; 5(6):906-11. PubMed ID: 2438389
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
    Steiner H, Leonhartsberger N, Stoehr B, Peschel R, Pichler R.
    Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Retroperitoneal lymphadenectomy and aggressive chemotherapy in nonbulky clinical Stage II nonseminomatous germinal testis tumors.
    Pizzocaro G, Zanoni F, Milani A, Piva L, Salvioni R, Pasi M, Pilotti S, Monfardini S.
    Cancer; 1984 Mar 15; 53(6):1363-8. PubMed ID: 6198070
    [Abstract] [Full Text] [Related]

  • 7. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003].
    Pizzocaro G, Schiavo M, Solima S, Vitellaro M, Biasoni N, Nicolai N.
    Urologia; 2010 Mar 15; 77 Suppl 17():50-6. PubMed ID: 21308676
    [Abstract] [Full Text] [Related]

  • 8. Postchemotherapy retroperitoneal lymph node dissection in patients presenting with very high HCG levels.
    Speir RW, Calaway AC, Einhorn LH, Foster RS, Cary C.
    Urol Oncol; 2020 Aug 15; 38(8):687.e19-687.e23. PubMed ID: 32448503
    [Abstract] [Full Text] [Related]

  • 9. [Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)].
    Nicolai N, Necchi A, Piva L, Stagni S, Catanzaro MA, Biasoni D, Milani A, Torelli T, Salvioni R.
    Urologia; 2010 Aug 15; 77(2):84-7. PubMed ID: 20890864
    [Abstract] [Full Text] [Related]

  • 10. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR, Belitsky P, Millard OH, Lannon SG.
    Can J Surg; 1993 Dec 15; 36(6):537-40. PubMed ID: 7504978
    [Abstract] [Full Text] [Related]

  • 11. Primary chemotherapy for clinical stage II nonseminomatous germ cell testicular tumors: selection criteria and long-term results.
    Lerner SE, Mann BS, Blute ML, Richardson RL, Zincke H.
    Mayo Clin Proc; 1995 Sep 15; 70(9):821-8. PubMed ID: 7543967
    [Abstract] [Full Text] [Related]

  • 12. Early clinical stages of nonseminomatous testis cancer. Evaluation of the primary treatment and follow-up procedures of the SWENOTECA project.
    Klepp O, Olsson AM, Ous S, Nilsson S, Høisaether PA, Tveter K.
    Scand J Urol Nephrol; 1991 Sep 15; 25(3):179-90. PubMed ID: 1658924
    [Abstract] [Full Text] [Related]

  • 13. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D, Ondrusova M, Hornak M, Matoska J.
    Neoplasma; 2007 Sep 15; 54(5):437-42. PubMed ID: 17688374
    [Abstract] [Full Text] [Related]

  • 14. Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors.
    Herr HW, Toner GC, Geller NL, Bosl GJ.
    Eur Urol; 1991 Sep 15; 19(1):1-5. PubMed ID: 1848821
    [Abstract] [Full Text] [Related]

  • 15. Case report: the danger of postchemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma.
    Spermon JR, Witjes JA.
    J Endourol; 2008 May 15; 22(5):1013-6. PubMed ID: 18429687
    [Abstract] [Full Text] [Related]

  • 16. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone.
    Coogan CL, Foster RS, Rowland RG, Bihrle R, Smith ER, Einhorn LH, Roth BJ, Donohue JP.
    Urology; 1997 Dec 15; 50(6):957-62. PubMed ID: 9426730
    [Abstract] [Full Text] [Related]

  • 17. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA.
    Semin Urol; 1993 May 15; 11(2):92-8. PubMed ID: 7689741
    [No Abstract] [Full Text] [Related]

  • 18. The role of chemotherapy and surgery in the treatment of retroperitoneal metastases in advanced nonseminomatous testis cancer.
    Vugrin D, Whitmore WF.
    Cancer; 1985 May 01; 55(9):1874-8. PubMed ID: 4038913
    [Abstract] [Full Text] [Related]

  • 19. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
    Spiess PE, Tannir NM, Brown GA, Liu P, Tu SM, Evans JG, Pisters LL.
    Urology; 2007 Dec 01; 70(6):1173-8. PubMed ID: 18158041
    [Abstract] [Full Text] [Related]

  • 20. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD, Foster RS, Bihrle R, Donohue JP.
    Urology; 2007 Mar 01; 69(3):557-9. PubMed ID: 17382165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.